Pay in 4 interest-free payments of $7.35 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
This means your microdose schedule is not just a pathway to a dose, it is the beginning of a long-term treatment relationship
Microdosing GLP-1 means using doses significantly below the approved therapeutic range, but this practice lacks clinical trial evidence and is not approved by the MHRA
The most common side effects reported in clinical trials were: Nausea Vomiting Diarrhea Stomach pain Constipation Weight loss Less common but more serious side effects include: Serious, lifethreatening allergic reactions Increased risk of certain thyroid tumors, including medullary thyroid carcinoma (MTC) Increased risk of multiple endocrine neoplasia syndrome type 2 (MEN 2) Pancreatitis (inflammation of the pancreas) Diabetic retinopathy complications and vision changes Low blood sugar (hypoglycemia), especially when used with other diabetes medications Worsening kidney disease Gallbladder disease and gallstones This list is not exhaustive
Due to their high surface area, charge density, and unique reactivity, nanomaterials can provoke cellular oxidative stress, mitochondrial dysfunction, lysosomal impairment, and activation of pro-inflammatory pathways [475,476,477,478]
